CUE logo

CUE
Cue Biopharma Inc

1,977
Mkt Cap
$82.65M
Volume
164,801.00
52W High
$41.42
52W Low
$4.97
PE Ratio
-3.64
CUE Fundamentals
Price
$20.10
Prev Close
$20.43
Open
$19.84
50D MA
$16.54
Beta
1.44
Avg. Volume
1M
EPS (Annual)
-$8.42
P/B
3.03
Rev/Employee
$947,103.45
$5.99
Loading...
Loading...
News
all
press releases
Small Cap Stocks To Follow Now - May 3rd
Inflection Point Acquisition Corp. II, Direxion Daily MU Bull 2X Shares, and Cue Biopharma are the three Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of publicly traded companies with relatively small market capitalizationstypically ro...
News Placeholder
More News
News Placeholder
Cue Biopharma (NASDAQ:CUE) Downgraded to Buy Rating by Wall Street Zen
Wall Street Zen lowered Cue Biopharma from a "strong-buy" rating to a "buy" rating in a research note on Sunday...
News Placeholder
Small Cap Stocks To Follow Now - May 2nd
Inflection Point Acquisition Corp. II, Direxion Daily MU Bull 2X Shares, Cue Biopharma, Esperion Therapeutics, and Akanda are the five Small Cap stocks to watch today, according to MarketBeat's stock...
News Placeholder
Top Small Cap Stocks To Add to Your Watchlist - May 1st
Inflection Point Acquisition Corp. II, Direxion Daily MU Bull 2X Shares, Cue Biopharma, Esperion Therapeutics, and Akanda are the five Small Cap stocks to watch today, according to MarketBeat's stock...
News Placeholder
This Market Is Moving Fast
The market is sending a clear signal: capital is flowing aggressively into platforms that can scale innovation, whether that’s next-generation immunotherapy, AI-driven digital ecosystems, or entirely new infrastructure for energy and materials. This week’s developments, from fresh biotech funding to explosive user growth in social platforms and bold pivots into clean energy, highlight a broader theme: investors are rewarding companies that are either accelerating commercialization or positioning themselves at critical bottlenecks in emerging industries. $CUE, $RDDT, $SOBR, $KBLB, $WTO, $AKAN
News Placeholder
Nasdaq, S&P 500 Futures Take A Breather Near Highs: Why AAPL, META, RDDT, RBLX, CUE Are Keeping Traders Engaged Today
Data from Stocktwits shows that retail traders are bullish on SPY and QQQ again.
News Placeholder
Cue Biopharma Stock Surges Over 65% Overnight: Why Is It Moving?
Cue Biopharma Inc. shares surged 67.57% after announcing a $30M financing, anti-IgE antibody license, and new CEO.read more...
News Placeholder
CUE Stock Jumps Over 100% After Hours — What’s Driving The Rally?
The company announced a $30 million private placement, licensed a new clinical-stage drug candidate, and appointed a new CEO.
News Placeholder
Cue Biopharma (NASDAQ:CUE) Raised to Strong-Buy at Wall Street Zen
Wall Street Zen upgraded shares of Cue Biopharma from a "buy" rating to a "strong-buy" rating in a research note on Saturday...
News Placeholder
Cue Biopharma (NASDAQ:CUE) Shares Gap Down - Here's Why
Cue Biopharma (NASDAQ:CUE) Shares Gap Down - Here's Why...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available